| Cavia porcellus |
Cavia porcellus |
Activity |
nan |
None |
10.1007/s00044-011-9641-1 |
| Cavia porcellus |
Cavia porcellus |
Activity |
nan |
None |
10.1016/j.bmcl.2022.129067 |
| Cavia porcellus |
Cavia porcellus |
Activity |
nan |
None |
10.1021/jm9008218 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
6.7 |
mg.kg-1 |
10.1016/j.bmcl.2009.03.057 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
6.8 |
mg.kg-1 |
10.1016/j.bmcl.2009.03.031 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
6.8 |
mg.kg-1 |
10.1021/jm9008218 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
38.5 |
mg.kg-1 |
10.1021/jm00212a003 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
nan |
None |
10.1016/j.bmcl.2009.03.031 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
80.0 |
% |
10.1021/jm00212a003 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
nan |
% |
10.1007/s00044-011-9641-1 |
| Cercopithecidae |
Monkey |
Antagonist potency |
nan |
None |
10.1021/jm00098a001 |
| Cercopithecidae |
Monkey |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00098a001 |
| Cercopithecidae |
Monkey |
PDC |
nan |
None |
10.1021/jm00098a001 |
| Cercopithecidae |
Monkey |
Physical dependence capacity |
nan |
None |
10.1021/jm00177a001 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2D6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
104000.0 |
nM |
10.1021/jm0209578 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
9300.0 |
nM |
10.1021/jm020164l |
| Homo sapiens |
Delta opioid receptor |
Ki |
52207.0 |
nM |
10.1021/jm701457j |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
301995.17 |
nM |
10.1016/j.bmcl.2005.03.080 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
CL |
15.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
1.7 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
55.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
Vdss |
3.5 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
4941.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
15000.0 |
nM |
10.1021/jm020164l |
| Homo sapiens |
Kappa opioid receptor |
Ki |
25411.0 |
nM |
10.1021/jm701457j |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
540.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
1100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
EC50 |
6100.0 |
nM |
10.1074/jbc.m703272200 |
| Homo sapiens |
Mu opioid receptor |
Emax |
81.3 |
% |
10.1074/jbc.m703272200 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
105.0 |
nM |
10.1021/jm020164l |
| Homo sapiens |
Mu opioid receptor |
Ki |
727.0 |
nM |
10.1021/jm701457j |
| Homo sapiens |
Mu opioid receptor |
Ki |
6300.0 |
nM |
10.1074/jbc.m703272200 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Opioid receptors; mu & delta |
Ratio |
89.0 |
None |
10.1021/jm020164l |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1021/jm701457j |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
7200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
K(p,uu,CSF) |
0.79 |
None |
10.1021/jm901036q |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Skin |
log Kp |
-7.68 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
5.7 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
0.7 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
0.8 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
1.0 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
235500.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
39.1 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-10 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-8 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B15 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B4 |
Activity |
nan |
None |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
1.8 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
54.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
80.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
114.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Km |
400000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Km |
1800000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Vmax |
9.0 |
pmol/min/mg protein |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Vmax |
74.0 |
pmol/min/mg protein |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
2.5 |
min |
10.1007/s00044-012-9977-1 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
Activity |
5.0 |
None |
10.1021/np0497649 |
| Mus musculus |
Mus musculus |
Activity |
17.0 |
None |
10.1016/j.ejmech.2018.12.066 |
| Mus musculus |
Mus musculus |
AD50 |
nan |
None |
10.1021/jm00370a019 |
| Mus musculus |
Mus musculus |
Behavior |
nan |
None |
10.1021/jm00056a010 |
| Mus musculus |
Mus musculus |
ED50 |
1.4 |
mg.kg-1 |
10.1021/jm00370a019 |
| Mus musculus |
Mus musculus |
ED50 |
2.3 |
mg.kg-1 |
10.1021/jm00352a037 |
| Mus musculus |
Mus musculus |
ED50 |
4.5 |
mg.kg-1 |
10.1021/jm00205a007 |
| Mus musculus |
Mus musculus |
ED50 |
4.5 |
mg.kg-1 |
10.1021/jm00218a021 |
| Mus musculus |
Mus musculus |
ED50 |
4.5 |
mg.kg-1 |
10.1021/jm00221a027 |
| Mus musculus |
Mus musculus |
ED50 |
5.8 |
mg.kg-1 |
10.1021/jm00190a020 |
| Mus musculus |
Mus musculus |
ED50 |
6.8 |
mg.kg-1 |
10.1021/jm00370a019 |
| Mus musculus |
Mus musculus |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00177a001 |
| Mus musculus |
Mus musculus |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00200a021 |
| Mus musculus |
Mus musculus |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00205a007 |
| Mus musculus |
Mus musculus |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00218a021 |
| Mus musculus |
Mus musculus |
ED50 |
7.5 |
mg.kg-1 |
10.1021/jm00221a027 |
| Mus musculus |
Mus musculus |
ED50 |
9.7 |
mg.kg-1 |
10.1021/jm00056a010 |
| Mus musculus |
Mus musculus |
ED50 |
10.2 |
umol.kg-1 |
10.1021/jm00186a025 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
mg.kg-1 |
10.1021/jm00355a012 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm00138a015 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm00138a016 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm00144a015 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm00176a013 |
| Mus musculus |
Mus musculus |
ED50 |
10.3 |
umol.kg-1 |
10.1021/jm00361a019 |
| Mus musculus |
Mus musculus |
ED50 |
14.5 |
mg.kg-1 |
10.1021/jm00370a019 |
| Mus musculus |
Mus musculus |
ED50 |
21.4 |
mg.kg-1 |
10.1021/jm00225a021 |
| Mus musculus |
Mus musculus |
ED50 |
38.97 |
mg.kg-1 |
10.1021/jm00352a037 |
| Mus musculus |
Mus musculus |
Mortality |
40.0 |
% |
10.1021/jm00056a010 |
| Mus musculus |
Opioid receptor |
IC50 |
10000.0 |
nM |
10.1021/jm00352a037 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Brain |
Fu |
0.62 |
None |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Kp |
1.99 |
None |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Vd |
3.2 |
L.kg-1 |
10.1124/dmd.110.035998 |
| Rattus norvegicus |
Brain |
Vdu |
3.2 |
ml |
10.1021/jm901036q |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cytochrome P450 2D1 |
IC50 |
1320000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D18 |
IC50 |
2216000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D2 |
IC50 |
238000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D3 |
IC50 |
4089000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver microsome |
CL |
8.35 |
mL.min-1.g-1 |
10.1016/j.bmc.2013.09.062 |
| Rattus norvegicus |
Liver microsome |
CL |
11.95 |
mL.min-1.g-1 |
10.1016/j.bmc.2013.09.062 |
| Rattus norvegicus |
Liver microsome |
CL |
18.65 |
mL.min-1.g-1 |
10.1016/j.bmc.2013.09.062 |
| Rattus norvegicus |
Liver microsome |
CL |
31.11 |
mL.min-1.g-1 |
10.1016/j.bmc.2013.09.062 |
| Rattus norvegicus |
Liver microsome |
CL |
47.97 |
mL.min-1.g-1 |
10.1016/j.bmc.2013.09.062 |
| Rattus norvegicus |
Mu opioid receptor |
Kp |
11.4 |
None |
10.1021/jm00398a007 |
| Rattus norvegicus |
Mu opioid receptor |
KT |
13.3 |
None |
10.1021/jm00398a007 |
| Rattus norvegicus |
Plasma |
Cp(f) |
0.21 |
uM |
10.1021/jm901036q |
| Rattus norvegicus |
Plasma |
Fu |
0.95 |
None |
10.1021/jm901036q |
| Rattus norvegicus |
Plasma |
K(p,uu,CSF) |
0.54 |
None |
10.1021/jm901036q |
| Rattus norvegicus |
Plasma |
logFu |
0.93 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
25.0 |
mm |
10.1021/jm00207a023 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
40.0 |
mm |
10.1021/jm00207a023 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm9008218 |
| Rattus norvegicus |
Rattus norvegicus |
DOSE |
50.0 |
mg.kg-1 |
10.1021/jm00355a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
5.7 |
mg.kg-1 |
10.1021/jm00355a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
75.0 |
umol.kg-1 |
10.1021/jm00138a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
75.0 |
umol.kg-1 |
10.1021/jm00144a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
75.0 |
umol.kg-1 |
10.1021/jm00176a013 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
75.0 |
umol.kg-1 |
10.1021/jm00186a025 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
75.1 |
umol.kg-1 |
10.1021/jm00138a016 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
nan |
None |
10.1016/j.bmcl.2009.03.031 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
2600.0 |
nM |
10.1021/jm00371a012 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
22000.0 |
nM |
10.1021/jm00371a012 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
20.0 |
% |
10.1021/jm00056a010 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
70.0 |
% |
10.1021/jm400143z |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
ADMET |
BPR |
2.7 |
None |
10.1021/jm901036q |
| None |
ADMET |
CL |
15.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
-0.8 |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
79.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
Fu |
0.93 |
None |
10.1021/jm030408h |
| None |
ADMET |
K(p,uu,brain) |
0.89 |
None |
10.1021/jm901036q |
| None |
ADMET |
log10(%HIA +10) |
2.021 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
MRT |
3.9 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Potency |
nan |
None |
10.1021/jm00177a001 |
| None |
ADMET |
T1/2 |
4.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
3.5 |
L.kg-1 |
10.1021/jm030408h |
| None |
ADMET |
Vdss |
3.5 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
NON-PROTEIN TARGET |
Fu |
0.7 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
No relevant target |
LogD |
-2.0 |
None |
10.1021/jm960073m |
| None |
No relevant target |
LogD |
-0.28 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD |
0.22 |
None |
10.1021/jm960073m |
| None |
No relevant target |
LogD |
0.23 |
None |
10.1021/jm0100990 |
| None |
No relevant target |
LogD |
1.19 |
None |
10.1021/jm960073m |
| None |
No relevant target |
LogP |
0.25 |
None |
10.1021/jm00398a007 |
| None |
No relevant target |
Log S |
-1.52 |
None |
10.1016/s0960-894x(00)00172-4 |
| None |
No relevant target |
Peff |
8.0 |
ucm/s |
10.1021/acs.jmedchem.9b01301 |
| None |
No relevant target |
pKa |
7.9 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKa |
8.2 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
8.2 |
None |
10.1016/j.ejmech.2009.06.004 |
| None |
No relevant target |
pKa |
8.2 |
None |
10.1021/jm030408h |
| None |
No relevant target |
pKa |
8.22 |
None |
10.1021/jm960073m |
| None |
No relevant target |
pKa |
8.4 |
None |
10.1124/dmd.110.035998 |
| None |
No relevant target |
pKa |
9.48 |
None |
10.1124/dmd.112.050278 |
| None |
Unchecked |
EC50 |
34700.0 |
nM |
10.1016/j.bmc.2007.10.030 |
| None |
Unchecked |
ED50 |
25.0 |
mg.kg-1 |
10.1021/jm020067s |
| None |
Unchecked |
ED50 |
27.0 |
mg.kg-1 |
10.1021/jm020067s |
| None |
Unchecked |
ED50 |
33.0 |
mg.kg-1 |
10.1021/jm020067s |
| None |
Unchecked |
Hepatotoxicity (acute) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
4320.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
IC50 |
20910.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Ki |
6900.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Km |
260.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Km |
370.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Km |
410.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Km |
430.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Km |
480.0 |
nM |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Ratio |
8.5 |
None |
10.1021/jm00371a012 |
| None |
Unchecked |
Ratio Ki |
35.0 |
None |
10.1021/jm701457j |
| None |
Unchecked |
Ratio Ki |
72.0 |
None |
10.1021/jm701457j |
| None |
Unchecked |
Vmax |
4.06 |
nmol/min/mg |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Vmax |
4.41 |
nmol/min/mg |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Vmax |
8.04 |
nmol/min/mg |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Vmax |
12.4 |
nmol/min/mg |
10.1016/j.bmc.2013.09.062 |
| None |
Unchecked |
Vmax |
12.51 |
nmol/min/mg |
10.1016/j.bmc.2013.09.062 |